LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in LianBio as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +1 vs. Q4 2021
- Shares held
- 85.9M
- −3.48M (−3.9%) vs. Q4 2021
- Total value
- $318.6M
- −$231.8M (−42.1%) vs. Q4 2021
- New holders
- 13
- 4 more added
- Sold out
- 12
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 74 | $0 | 0.00% | −84,282−99.9% | Reduced |
| FNY Investment Advisers, LLC | 800 | $2.00K | 0.00% | +800 | New |
| Morgan Stanley | 4,019 | $15.0K | 0.00% | +4,019 | New |
| Tower Research Capital LLC (TRC) | 5,903 | $22.0K | 0.00% | +5,903 | New |
| Old Well Partners, LLC | 19,200 | $71.0K | 0.05% | +7,500+64.1% | Added |
| JPMorgan Chase & Co | 20,000 | $74.0K | 0.00% | +20,000 | New |
| Vident Investment Advisory, LLC | 19,913 | $74.0K | 0.00% | +19,913 | New |
| Marshall Wace, LLP | 26,457 | $98.0K | 0.00% | −126,491−82.7% | Reduced |
| UBS Group AG | 33,491 | $124.0K | 0.00% | +33,491 | New |
| Renaissance Technologies LLC | 36,524 | $136.0K | 0.00% | +36,524 | New |
| Bailard, Inc. | 36,900 | $137.0K | 0.00% | +36,900 | New |
| Goldman Sachs Group Inc | 43,185 | $160.0K | 0.00% | +43,185 | New |
| Thrivent Financial for Lutherans | 49,505 | $184.0K | 0.00% | +49,505 | New |
| Manufacturers Life Insurance Company, The | 77,784 | $277.7K | 0.00% | +77,784 | New |
| MYDA Advisors LLC | 86,000 | $319.0K | 0.13% | +66,000+330.0% | Added |
| Alps Advisors Inc | 110,219 | $409.0K | 0.00% | −11,597−9.5% | Reduced |
| TD Asset Management Inc | 154,919 | $575.0K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 173,460 | $664.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 187,318 | $695.0K | 0.00% | −108,521−36.7% | Reduced |
| Laurion Capital Management LP | 200,000 | $742.0K | 0.02% | 00.0% | Unchanged |
| Casdin Capital, LLC | 206,415 | $766.0K | 0.03% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 275,007 | $1.02M | 0.17% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 325,000 | $1.21M | 0.48% | +252,594+348.9% | Added |
| Alyeska Investment Group, L.P. | 339,242 | $1.26M | 0.01% | +54,392+19.1% | Added |
| Logos Global Management LP | 412,837 | $1.53M | 0.20% | 00.0% | Unchanged |
| Citigroup Inc | 533,795 | $1.98M | 0.00% | +533,795 | New |
| Citadel Advisors LLC | 708,306 | $2.63M | 0.00% | +708,306 | New |
| Hudson Bay Capital Management LP | 713,743 | $2.65M | 0.04% | 00.0% | Unchanged |
| SCHF (Gpe), LLC | 937,500 | $3.48M | 1.08% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,500,000 | $5.57M | 0.02% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 1,518,969 | $5.63M | 0.00% | −1,685,761−52.6% | Reduced |
| Price T Rowe Associates Inc | 2,242,389 | $8.09M | 0.00% | 00.0% | Unchanged |
| Vida Ventures Advisors, LLC | 2,282,084 | $8.47M | 4.92% | 00.0% | Unchanged |
| Tybourne Capital Management (HK) Ltd | 3,314,173 | $12.3M | 0.73% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,378,341 | $20.0M | 3.23% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,655,015 | $28.4M | 0.62% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 56,319,960 | $208.9M | 4.34% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,782,747−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −119,453−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −44,432−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −37,365−100.0% | Sold out |
| Element Capital Management LLC | 0 | $0 | 0.00% | −20,157−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −19,957−100.0% | Sold out |
| Cna Financial Corp | 0 | $0 | 0.00% | −15,993−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −11,095−100.0% | Sold out |